SILENCE THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.690 USD | +5.18% |
|
+11.13% | -17.30% |
Chart calendar Silence Therapeutics plc
3b3d511.JqFuV0SCP1TrBbwSV_kRVLV3VMPpvtWrF2pPirM3gxg.bpc7DRTEcRWFSONwZ8tDBdQZC6av7LrMSBo_wdZH8y1D0VkkELBKBoY1-Q~1950c207acde90d5938914130d4de4c3
Upcoming events on Silence Therapeutics plc
Past events on Silence Therapeutics plc
| 2024-12-08 07:45 pm | American Society of Hematology Meeting - Abstract Number: 656 |
| 2024-12-04 10:00 am | Piper Sandler Healthcare Conference |
| 2024-11-20 09:00 am | Jefferies London Healthcare Conference |
| 2024-11-17 | American Heart Association Scientific Meeting |
| 2024-11-14 08:00 am | Q3 2024 Earnings Release |
| 2024-09-30 09:00 am | Chardan Genetic Medicines Conference |
| 2024-09-17 10:20 am | Cantor Global Healthcare Conference |
| 2024-09-10 11:30 am | H.C. Wainwright Global Investment Conference |
| 2024-09-05 05:35 pm | Morgan Stanley Healthcare Conference |
| 2024-08-15 07:30 am | Q2 2024 Earnings Release |
| 2024-06-27 08:30 am | SANRECO Phase 1 Study Results Call |
| 2024-06-06 02:30 pm | Jefferies Global Healthcare Conference |
| 2024-05-20 02:30 pm | H.C. Wainwright BioConnect Investor Conference |
| 2024-05-17 08:00 am | Annual General Meeting |
| 2024-05-16 08:30 am | Q1 2024 Earnings Release |
| 2024-03-13 08:00 am | Q4 2023 Earnings Call |
| 2024-03-13 07:05 am | Q4 2023 Earnings Release |
| 2024-02-07 01:30 pm | Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat |
| 2023-11-15 11:30 am | Jefferies London Healthcare Conference |
| 2023-11-14 07:00 am | Q3 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 12,4 13,5 -8.22% | 17,5 23,7 -26.26% | 25,4 29,0 -12.5% | 20,7 | 28,0 | 17,0 |
|
EBITDA Million GBP | Released Forecast Spread | -45,4 -39,3 -15.49% | -48,1 0,00 - | -49,1 -54,9 10.61% | -61,6 | -51,7 | -95,4 |
|
EBIT Million GBP | Released Forecast Spread | -45,8 -44,5 -3.06% | -48,6 -42,7 -13.87% | -49,6 -46,4 -6.93% | -61,0 | -59,1 | -91,2 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -45,9 -45,8 -0.04% | -47,4 -39,9 -18.69% | -50,3 -41,6 -20.8% | -68,4 | -76,1 | -92,5 |
|
Net income Million GBP | Released Forecast Spread | -39,4 -42,8 7.83% | -40,5 -33,0 -22.69% | -43,3 -34,4 -25.95% | -61,1 | -72,9 | -89,3 |
|
EPS USD | Released Forecast Spread | -1,74 -2,36 26.27% | -1,53 -1,55 1.54% | -1,49 -0,86 -73.74% | -0,56 | -0,69 | -0,69 |
| Announcement Date | 17/03/22 | 15/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | September | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 8,14 11,2 -27.6% | 11,4 2,50 354.96% | 9,10 3,07 196.87% | 2,80 2,40 16.58% | 2,10 9,20 -77.18% | 12,4 3,55 249.46% | 0,60 9,85 -93.93% | 1,14 3,00 -61.93% | 3,73 | 3,05 | 3,00 | 3,00 | 3,05 |
|
EBITDA Million GBP | Released Forecast Spread | -18,2 -13,5 -34.84% | -22,4 -14,6 -53.58% | -15,7 | ||||||||||
|
EBIT Million GBP | Released Forecast Spread | -24,6 -28,6 14.08% | -12,1 -14,0 13.07% | -11,5 -16,3 29.54% | -12,7 -16,5 23.15% | -13,3 -6,28 -111.92% | -4,16 -12,5 66.75% | -18,3 -13,6 -34.73% | -22,5 -14,3 -58.15% | -17,4 | ||||
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -24,4 -27,6 11.65% | -12,7 -13,9 8.74% | -12,0 -16,2 25.9% | -10,7 -16,5 35.32% | -15,0 -6,28 -138.48% | -3,37 -12,5 73.08% | -17,4 -13,6 -28.24% | -30,2 -14,3 -111.64% | -17,4 | ||||
|
Net income Million GBP | Released Forecast Spread | -27,7 -24,2 -14.54% | -10,2 -12,5 18.57% | -10,4 -15,1 31.01% | -8,25 -15,2 45.75% | -14,4 -5,48 -163.21% | -1,88 -2,90 35.31% | -15,6 -12,0 -29.68% | -27,0 -13,5 -100.83% | -16,6 | ||||
|
EPS USD | Released Forecast Spread | -0,73 -0,79 8.08% | -0,36 | -0,37 -0,67 45.26% | -0,27 -0,59 53.62% | -0,48 -0,20 -139.24% | -0,05 -0,03 -98.95% | -0,43 -0,09 -355.08% | -0,73 -0,14 -435.13% | -0,16 | -0,17 | -0,18 | -0,19 | -0,22 |
| Announcement Date | 15/03/23 | 16/05/23 | 16/08/23 | 14/11/23 | 13/03/24 | 16/05/24 | 15/08/24 | 14/11/24 | - | - | - | - | - |
| 2025-01-28 | LONZA GROUP AG: Q4 2024 Earnings Release |
| 2025-02-05 06:30 am | BIO-TECHNE CORPORATION: Q2 2025 Earnings Release |
| 2025-02-05 04:05 pm | QIAGEN N.V.: Q4 2024 Earnings Release |
| 2025-02-05 | REPLIMUNE GROUP, INC.: Q3 2025 Earnings Release (Projected) |
| 2025-02-06 07:00 am | IQVIA HOLDINGS INC.: Q4 2024 Earnings Release |
| 2025-02-09 | MEDPACE HOLDINGS, INC.: Q4 2024 Earnings Release |
| 2025-02-10 | AZENTA, INC.: Q1 2025 Earnings Release (Projected) |
| 2025-02-11 | IMMUNOVANT, INC.: Q3 2025 Earnings Release (Projected) |
| 2025-02-11 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: Q4 2024 Earnings Release (Projected) |
| 2025-02-12 04:01 pm | GALAPAGOS NV: Q4 2024 Earnings Release |
Past sector events for Silence Therapeutics plc
| 2025-01-23 04:30 am | SYNGENE INTERNATIONAL LIMITED: Q3 2025 Earnings Release |
| 2025-01-15 02:00 am | GENUS PLC: Q2 2025 Sales and Revenue Release - Trading Update |
| 2025-01-10 12:34 am | POLARIS GROUP: December 2024 Sales and Revenue Release |
| 2024-12-09 03:53 am | POLARIS GROUP: November 2024 Sales and Revenue Release |
| 2024-11-27 | FORMYCON AG: Q3 2024 Earnings Release |
| 2024-11-20 07:00 am | SEPTERNA, INC.: Q3 2024 Earnings Release |
| 2024-11-20 02:00 am | GENUS PLC: Q1 2025 Sales and Revenue Release - Trading Update |
| 2024-11-14 08:00 am | ARRIVENT BIOPHARMA, INC.: Q3 2024 Earnings Release |
| 2024-11-14 08:00 am | SILENCE THERAPEUTICS PLC: Q3 2024 Earnings Release |
| 2024-11-14 02:00 am | BIOARCTIC AB: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SLN Stock
- Calendar Silence Therapeutics plc